针对罗波林-1的TCR工程T细胞构成了对三阴性乳腺癌的安全有效治疗方法
Dian Kortleve1,2, Dora Hammerl1,2,3, Mandy van Brakel1,2
1Laboratory of Tumor Immunology, Erasmus MC, Rotterdam, the Netherlands.
Cancer discovery
|August 22, 2024
概括
研究人员确定了Ropporin-1 (ROPN1) 作为治疗三阴性乳腺癌 (TNBC) 的有希望的标. 针对ROPN1的T细胞疗法对患有这种侵袭性癌症的患者具有显著的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 对新型治疗策略的巨大未满足需求.
- 罗波林-1 (ROPN1) 被确定为TNBC中的高度表达和特定标,在健康组织中不存在.
研究的目的:
- 发现和验证Ropporin-1 (ROPN1) 作为三阴性乳腺癌 (TNBC) 的治疗标.
- 开发和临床前评估针对ROPN1的T细胞受体 (TCR) 工程T细胞用于TNBC治疗.
主要方法:
- 免疫学和计算预测确定了人类白细胞抗原-A2结合.
- 选择T细胞受体 (TCRs) 来自原始的曲目,并将其改造为T细胞.
- 实验室瘤和体内瘤模型被用于评估TCR介导的细胞毒性和疗效.
主要成果:
- 确定了针对ROPN1表位体FLYTYIAKV的高度特定的TCR,没有显示交叉反应.
- 工程T细胞在体内有效地杀死TNBC瘤细胞和瘤细胞,优于标准治疗.
- 该TCR-T细胞产品在临床前试验中达到安全性和有效性标准.
结论:
- 罗波林-1 (ROPN1) 是大多数三阴性乳腺癌 (TNBC) 患者的验证治疗标.
- 抗ROPN1 TCR T细胞代表了TNBC的有前途和特异性免疫疗法,具有良好的安全性和有效性.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.3K
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.1K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493